Publisher
Springer Berlin Heidelberg
Reference27 articles.
1. Acland KM, Healy C, Calonje E et al. (2001) Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma. J Clin Oncol 19:2674–2678
2. Akhurst AT, Nguyen T, Larson StM, Coit DG, Brady MS (1999) PET scanning with F18 2 fluoro-2-deoxy-D-glucose (FDG) in patients with melanoma:Benefits and limitations. Clin Pos Imag 2:93–98
3. Barrington SF, Maisey MN (1996) Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam. J Nucl Med 37:1127–1129
4. Baum RP, Rinne D, Zollner TM, Adams S, Hertel A, Kaufmann R, Hör G (1996) F-18-FDG PET for staging of high risk melanoma and restaging of recurrences: results of a prospective study and influence on therapeutic management. J Nucl Med 37:137P
5. Belhocine T, Pierard G, De Labrassine M et al. (2002) Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection. The Oncologist 7:271–278